Does NARATRIPTAN Cause Product use in unapproved indication? 32 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Product use in unapproved indication have been filed in association with NARATRIPTAN (Naratriptan). This represents 6.1% of all adverse event reports for NARATRIPTAN.
32
Reports of Product use in unapproved indication with NARATRIPTAN
6.1%
of all NARATRIPTAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product use in unapproved indication From NARATRIPTAN?
Of the 32 reports.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NARATRIPTAN. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does NARATRIPTAN Cause?
Drug ineffective (186)
Migraine (111)
Nausea (87)
Dyspnoea (82)
Treatment failure (79)
Diarrhoea (76)
Cough (72)
Weight decreased (71)
Abdominal pain (65)
Dyspepsia (60)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which NARATRIPTAN Alternatives Have Lower Product use in unapproved indication Risk?
NARATRIPTAN vs NASONEX
NARATRIPTAN vs NATALIZUMAB
NARATRIPTAN vs NATALIZUMAB-SZTN
NARATRIPTAN vs NATAMYCIN
NARATRIPTAN vs NATEGLINIDE